These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27989931)

  • 41. Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials.
    Denzen EM; Santibáñez ME; Moore H; Foley A; Gersten ID; Gurgol C; Majhail NS; Spellecy R; Horowitz MM; Murphy EA
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):183-9. PubMed ID: 21806948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation Patients.
    Salit RB; Schoeppner K; De Biase C; Mohammed J; Gonzales AL; Hashmi SK; Gea-Banacloche J; Savani BN; Carpenter PA; Syrjala KL
    Transplant Cell Ther; 2022 Dec; 28(12):822-828. PubMed ID: 36184059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
    DeFilipp Z; Duarte RF; Snowden JA; Majhail NS; Greenfield DM; Miranda JL; Arat M; Baker KS; Burns LJ; Duncan CN; Gilleece M; Hale GA; Hamadani M; Hamilton BK; Hogan WJ; Hsu JW; Inamoto Y; Kamble RT; Lupo-Stanghellini MT; Malone AK; McCarthy P; Mohty M; Norkin M; Paplham P; Ramanathan M; Richart JM; Salooja N; Schouten HC; Schoemans H; Seber A; Steinberg A; Wirk BM; Wood WA; Battiwalla M; Flowers ME; Savani BN; Shaw BE
    Bone Marrow Transplant; 2017 Feb; 52(2):173-182. PubMed ID: 27548466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late congestive heart failure after hematopoietic cell transplantation.
    Armenian SH; Sun CL; Francisco L; Steinberger J; Kurian S; Wong FL; Sharp J; Sposto R; Forman SJ; Bhatia S
    J Clin Oncol; 2008 Dec; 26(34):5537-43. PubMed ID: 18809605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers.
    Cowens-Alvarado R; Sharpe K; Pratt-Chapman M; Willis A; Gansler T; Ganz PA; Edge SB; McCabe MS; Stein K
    CA Cancer J Clin; 2013 May; 63(3):147-50. PubMed ID: 23512728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.
    Sato T; Konuma T; Miwa Y; Sugihara N; Tsuru Y; Narita H; Kiriyama S; Kato S; Oiwa-Monna M; Kobayashi K; Takahashi S; Tojo A
    Ann Hematol; 2017 Nov; 96(11):1841-1847. PubMed ID: 28815326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late effects following hematopoietic cell transplantation for children.
    Dahllöf G; Hingorani SR; Sanders JE
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):88-93. PubMed ID: 18162227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
    Weisdorf D; Carter S; Confer D; Ferrara J; Horowitz M
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):257-62; discussion 255-6. PubMed ID: 17317578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention.
    Armenian SH; Ryan TD; Khouri MG
    Heart Fail Clin; 2017 Apr; 13(2):337-345. PubMed ID: 28279419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies.
    Mehta PA; Rotz SJ; Majhail NS
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):e11-e19. PubMed ID: 30244107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biobehavioral Research and Hematopoietic Stem Cell Transplantation: Expert Review from the Biobehavioral Research Special Interest Group of the American Society for Transplantation and Cellular Therapy.
    Kelly DL; Syrjala K; Taylor M; Rentscher KE; Hashmi S; Wood WA; Jim H; Barata A; Flynn KE; Burns LJ; Shaw BE; Petersdorf E; Yero AC; Emmrich AD; Morris KE; Costanzo ES; Knight JM
    Transplant Cell Ther; 2021 Sep; 27(9):747-757. PubMed ID: 34139388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients.
    Solh MM; Bashey A; Solomon SR; Morris LE; Zhang X; Brown S; Holland HK
    Bone Marrow Transplant; 2018 May; 53(5):576-583. PubMed ID: 29335633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survivorship: adult cancer survivors.
    Ganz PA
    Prim Care; 2009 Dec; 36(4):721-41. PubMed ID: 19913184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.
    Shankar SM; Carter A; Sun CL; Francisco L; Baker KS; Gurney JG; Weisdorf DG; Forman SJ; Robison LL; Grant M; Bhatia S
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):834-9. PubMed ID: 17416780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network.
    Horwitz EM; Horowitz MM; DiFronzo NL; Kohn DB; Heslop HE;
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):192-6. PubMed ID: 21182973
    [No Abstract]   [Full Text] [Related]  

  • 58. Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative.
    Denzen EM; Majhail NS; Stickney Ferguson S; Anasetti C; Bracey A; Burns L; Champlin R; Chell J; Leather H; Lill M; Maziarz RT; Medoff E; Neumann J; Schmit-Pokorny K; Snyder EL; Wiggins L; Yolin Raley DS; Murphy EA
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):4-11. PubMed ID: 23078785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment.
    Majhail NS; Murphy EA; Denzen EM; Ferguson SS; Anasetti C; Bracey A; Burns L; Champlin R; Hubbard N; Markowitz M; Maziarz RT; Medoff E; Neumann J; Schmit-Pokorny K; Weisdorf DJ; Yolin Raley DS; Chell J; Snyder EL
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):172-82. PubMed ID: 22178961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research.
    Elena JW; Travis LB; Simonds NI; Ambrosone CB; Ballard-Barbash R; Bhatia S; Cerhan JR; Hartge P; Heist RS; Kushi LH; Lash TL; Morton LM; Onel K; Pierce JP; Robison LL; Rowland JH; Schrag D; Sellers TA; Seminara D; Shu XO; Thomas NE; Ulrich CM; Freedman AN
    J Natl Cancer Inst; 2013 Jan; 105(2):85-94. PubMed ID: 23197494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.